The preparation of evidence-based guidelines is highlighted by the WHO as an important component in the concerted effort to eliminate avoidable blindness. [149] This review has highlighted ...

Please provide your email address to receive an email when new articles are posted on . Regillo discussed treatment with panretinal photocoagulation vs. anti-VEGF therapy, as well as when to use both.

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. About 7% of youths with type 2 diabetes have diabetic ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...

Type 2 diabetes is among the top causes of vision loss and blindness across the world. According to studies, visual impairment due to diabetic retinopathy has increased significantly in the last 20 ...

Hypertensive retinopathy occurs due to high blood pressure, while diabetic retinopathy results from diabetes. Both are eye diseases affecting the retina. Retinopathy is an eye disease affecting the ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Diabetic retinopathy involves damage to the eye’s retina due to high blood sugar levels in the body. It is a common complication of diabetes, affecting millions of people with both type 1 and type 2 ...

Expert Rev Ophthalmol. 2012;7(5):417-439. The criteria for inclusion were based on research questions set by the NHMRC multidisciplinary expert panel working group for guideline development.